Omlyclo is used for the treatment of moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps, ...
STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as ...
Biocon Biologics, one of India's leading biologic drug manufacturers, announced on Friday the results of a Phase-3 study on a ...
Elevidys is a biologic drug, which means it’s made from parts of living organisms. It doesn’t come in a biosimilar form. Biosimilars are like generic drugs, but unlike generics (which are made ...
The FDA has approved Celltrion’s OMLYCLO (omalizumab-igec) as the first and only biosimilar designated as interchangeable ...
FourStatesHomepage.com on MSN2d
‘My health is in jeopardy’: Insurance denies Kansas nursing student’s prescriptionA college student from Anthony is speaking out after Blue Cross and Blue Shield of Kansas denied a medicine she has been ...
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for ...
Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...
Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback